Streetbeat News

Products Services

BABA

ENSC

RUM

Rumble (RUM) announced the public launch of Rumble Studio, leading to a 19% stock increase. Ensysce Biosciences (ENSC) revealed that the FDA granted Breakthrough Therapy Designation for PF614-MPAR, causing a 59% surge in its stock. Bloomberg reported that China is considering a $278B stock market rescue package, which resulted in a 7% rise in Alibaba's (BABA) shares.

Portfolio Pulse from ryanfaloona@benzinga.com

January 23, 2024 | 1:37 pm

NXL

Nexalin Technology has received a title for its 'Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) System'. This development could indicate progress in the company's technology and potential for future growth.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 1:34 pm

AMPX

Amprius Technologies, Inc. (NYSE:AMPX) has received the AS9100:2016 certification for its Fremont, CA production facility, demonstrating its commitment to high-quality standards in the aerospace and defense industries. The certification, which is specific to the aerospace sector, complements the company's renewed ISO9001:2015 certification. This achievement is expected to support Amprius' supply of batteries to the electric aviation industry, including eVTOLs, HAPS, and drones.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 1:33 pm

PPSI

Pioneer Power Solutions, Inc. (NASDAQ:PPSI) has partnered with NOMAD Transportable Power Systems to launch new zero-emission, mobile EV charging platforms, ZEeB and EXZELCR. These platforms offer off-grid charging solutions with battery energy storage, targeting a variety of markets such as events, remote locations, disaster response, and fleet management. The initial ZEeB unit has a 500 kW power capacity and uses KORE Power lithium-ion battery cells. Larger units and the EXZELCR recharging platform are planned for later this year. The products are designed to enhance EV charging flexibility and support the transition to Net Zero emissions.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 1:31 pm

KOPN

Kopin Corporation (NASDAQ:KOPN) announced receiving an initial production order for the CR3 wearable surgical monitor from HMDmd Inc. The CR3 is a head-mounted display designed for surgical use, offering full-HD resolution 3-D imagery and compatibility with 2-D and 3-D endoscopes and operating microscopes. It aims to improve ergonomics and ease of access to critical information for surgeons. Financial terms of the deal were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 1:31 pm

GE

General Electric's CFO indicated that the performance of the company's renewable energy segment in Q1 will be similar to its performance in Q4 during a conference call.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 1:28 pm

TDY

Teledyne FLIR Defense, a unit of Teledyne Technologies Incorporated (NYSE:TDY), introduced the ThermoSight HISS-HD thermal sniper sight at the SHOT Show in Las Vegas. The sight allows precision shooters to detect and engage targets over 2,200 meters away. It mounts on MIL-STD-1913 rail interfaces and is compatible with various scopes and weapon platforms. The HISS-HD offers high-definition imagery and can be used for long-range sniping and surveillance missions. It also features an optional remote-control pendant for enhanced stability and reduced movement.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 1:26 pm

WOOF

Nationwide and Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) have launched a co-branded pet insurance product available on petco.com. The insurance offers customizable policies, covering accidental injuries, illnesses, and wellness care, with options to adjust reimbursement rates, deductibles, and coverage limits. Members also get discounts on Petco's veterinary services. The partnership aims to provide affordable, integrated pet health solutions, enhancing Petco's health and wellness ecosystem.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 1:25 pm

BMY

PFE

Bristol Myers Squibb (BMY) reported that its Opdivo plus Yervoy combination therapy showed sustained benefits over Pfizer's (PFE) Sutent in treating advanced kidney cancer after 8 years of follow-up in the Phase 3 CheckMate -214 trial. The combination therapy reduced the risk of death by 28% and showed improvements in overall survival, progression-free survival, overall response rate, and duration of response compared to Sutent. These results will be presented at the upcoming American Society of Clinical Oncology 2024 Genitourinary Cancers Symposium. BMY shares saw a premarket increase of 0.52%.

Portfolio Pulse from Vandana Singh

January 23, 2024 | 1:23 pm

VCIG

VCI Global Limited (NASDAQ:VCIG) has secured a consultancy deal with a Singapore-based Fin-MedTech Medical Group for its upcoming IPO on Nasdaq, expected to be completed in 2024/2025. VCI Global will provide services including equity structure, capital market strategy, and regulatory approval assistance. The company will be compensated in shares, with estimated income from the deal between USD 4 million to USD 8 million.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 1:22 pm